SCHEMBL29539637

SCHEMBL29539637

CCS(=O)(=O)N(C)c1cccc(-c2nn(-c3ccc(-c4ccccc4)cc3)c(=O)c3ccccc23)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.58
NPSR1 Q6W5P4 4/20 0.50
ALDH1A1 P00352 4/20 0.50
LMNA P02545 1/20 0.50
PDE4A P27815 1/20 0.50
PDE4B Q07343 1/20 0.50
PDE4C Q08493 1/20 0.50
PDE4D Q08499 1/20 0.50
GAA P10253 2/20 0.47
KDM4E B2RXH2 2/20 0.47
CYP2C9 P11712 2/20 0.47
CYP2C19 P33261 2/20 0.47
HTT P42858 2/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2D6 P10635 1/20 0.47
ENPP1 P22413 1/20 0.47
PSMB5 P28074 4/20 0.44
PSMB1 P20618 1/20 0.44
BRD4 O60885 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22721778 1.00 ALOX5 (0.58) ALOX5NPSR1ALDH1A1LMNAPDE4A
SCHEMBL29539552 0.92 NPSR1 (0.51) ALOX5NPSR1ALDH1A1LMNAPDE4A
SCHEMBL29539556 0.92 NPSR1 (0.51) ALOX5NPSR1ALDH1A1LMNAPDE4A
SCHEMBL22721685 0.92 NPSR1 (0.51) ALOX5NPSR1ALDH1A1LMNAPDE4A
SCHEMBL29539598 0.89 NPSR1 (0.59) ALOX5NPSR1ALDH1A1LMNAPDE4A
SCHEMBL22721536 0.89 NPSR1 (0.59) ALOX5NPSR1ALDH1A1LMNAPDE4A
SCHEMBL22721877 0.87 NPSR1 (0.48) ALOX5NPSR1ALDH1A1LMNAPDE4A
SCHEMBL29539559 0.87 NPSR1 (0.48) ALOX5NPSR1ALDH1A1LMNAPDE4A
SCHEMBL22721546 0.85 NPSR1 (0.57) ALOX5NPSR1ALDH1A1LMNAPDE4A
SCHEMBL29539373 0.85 NPSR1 (0.57) ALOX5NPSR1ALDH1A1LMNAPDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113840820-B Phthalazinone compounds and uses thereof ST制药株式会社 2024-05-03 CN claimed
US-20220235011-A1 PHTHALAZINONE COMPOUNDS AND USE THEREOF ST PHARM CO., LTD. (KR) 2022-07-28 US claimed
EP-3978480-A1 PHTHALAZINONE COMPOUNDS AND USE THEREOF ST Pharm Co., Ltd. (KR) 2022-04-06 EP claimed
CN-113840820-B Phthalazinone compounds and uses thereof ST制药株式会社 2024-05-03 CN disclosed
US-20220235011-A1 PHTHALAZINONE COMPOUNDS AND USE THEREOF ST PHARM CO., LTD. (KR) 2022-07-28 US disclosed
EP-3978480-A1 PHTHALAZINONE COMPOUNDS AND USE THEREOF ST Pharm Co., Ltd. (KR) 2022-04-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220235011-A1 PHTHALAZINONE COMPOUNDS AND USE THEREOF SIRT6, SIRT1, SIRT2 ALOX5 1553/4885NPSR1 2979/4885ALDH1A1 1433/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.